Comparing two seizure prevention drugs for women with severe preeclampsia
Treatments studied
Part of Brain & nervous system, Women’s health & pregnancy clinical trials.
This trial compares a common seizure medication (levetiracetam) with the standard drug (magnesium sulfate) to see which works better at preventing seizures in women with severe preeclampsia, a complication of pregnancy. If you are pregnant or have recently given birth and have severe preeclampsia or HELLP syndrome, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old
- You are pregnant or have given birth in the last few weeks
- You have severe preeclampsia, HELLP syndrome, or preeclampsia that started before pregnancy
- You are at risk for seizures and need preventive treatment
- You have been on magnesium for less than 2 hours or stopped it more than 48 hours ago
- You are being admitted to the hospital or will deliver soon
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different doses of magnesium sulfate to control seizures in overweight and obese women with preeclampsia. The goal is to find which dose works better and is safer for you and your baby.
This trial tests whether a water pill (furosemide) helps women recover better after severe preeclampsia—a serious pregnancy complication marked by very high blood pressure. You'll be in the hospital postpartum, and researchers want to see if the medication speeds recovery and reduces complications.
This study looks at different ways to give magnesium sulphate to women with severe preeclampsia to find the best treatment plan.
This trial studies how certain blood markers and brain-wave signals change in pregnant people with severe preeclampsia, especially when it leads to eclampsia (seizures). The goal is to better understand warning signs and treatment response to keep mother and baby safer.
This trial tests whether giving the seizure medication levetiracetam early can prevent or treat brain problems in people with septic shock. Septic shock is a life-threatening infection that can affect the brain, and this study aims to see if this drug helps protect brain function.
This study looks at how biomarkers (specific substances in your blood) might help doctors better manage postpartum preeclampsia—high blood pressure and other symptoms that can appear after having a baby. You may qualify if you have severe preeclampsia during delivery or are receiving standard care after delivery.
Hear when a new Severe Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.